Edition:
India

People: Atossa Genetics Inc (ATOS.OQ)

ATOS.OQ on NASDAQ Stock Exchange Capital Market

1.79USD
18 Oct 2019
Change (% chg)

$0.03 (+1.70%)
Prev Close
$1.76
Open
$1.76
Day's High
$1.79
Day's Low
$1.76
Volume
55,283
Avg. Vol
62,042
52-wk High
$7.39
52-wk Low
$0.81

Chen, Shu-Chih 

Dr. Shu-Chih Chen, Ph.D., is Director of Atossa Genetics Inc., effective August 15, 2014. Prior to that. Dr. Chen has served as a director since April 2009. Dr. Chen was a founder of the Company and served as Chief Scientific Officer of the Company since it was incorporated in April 2009 through August 2014. Dr. Chen was an Associate Professor at National Yang Ming University, Taipei, Taiwan, and served as the principal investigator of an NIH RO1 grant studying tumor suppression by gap junction protein connexin 43 at the Department of Molecular Medicine at Northwest Hospital, Seattle, WA. Dr. Chen has two issued U.S. patents and 20 pending U.S. patent applications related to cancer therapeutics. Dr. Chen received her Ph.D. degree in microbiology and public health from Michigan State University in 1992 and has published extensively on molecular oncology. Dr. Chen received her B.S. degree in medical technology from National Yang Ming University, Taipei, Taiwan in 1984. Dr. Chen was selected to serve on the Company’s Board of Directors because of her role as a founder of the Company and her qualifications in medical technology and as a professor and researcher in the field of cancer therapeutics.

Basic Compensation

Total Annual Compensation, USD 224,268
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 162,469
Fiscal Year Total, USD 386,737

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --